Table 3.
Costs and outcomes of each pathway (in screening population of 698 500 pregnant women), using national data
| Testing strategy | Screening | NIPT (£250) | Invasive testing | Total costs (£000) | DS positive | IPD related miscarriage (No) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No | Test positive | £000 | No | £000 | Direct No | After NIPT No | £000 | NIPT or IPD | Confirmed by IPD | |||||
| Current | 462 407 | 10 635 | 13 312 | 0 | 0 | 5743 | 0 | 3733 | 17 045 | 577 | 577 | 29 | ||
| NIPT ≥1/1000 | 462 407 | 45 316 | 13 312 | 32 160 | 8940 | 2127 | 297 | 1576 | 23 829 | 833 | 732 | 12 | ||
| NIPT ≥1/500 | 462 407 | 26 357 | 13 312 | 18 795 | 5225 | 2127 | 282 | 1566 | 20 103 | 814 | 719 | 12 | ||
| NIPT ≥1/150 | 462 407 | 10 635 | 13 312 | 7711 | 2143 | 2127 | 248 | 1544 | 17 000 | 772 | 688 | 12 | ||
| NIPT ≥1/1000—no direct IPD | 462 407 | 45 316 | 13 312 | 34 128 | 9487 | 0 | 664 | 432 | 23 231 | 826 | 601 | 3 | ||
| NIPT ≥1/500—no direct IPD | 462 407 | 26 357 | 13 312 | 20 762 | 5772 | 0 | 649 | 422 | 19 506 | 807 | 587 | 3 | ||
| NIPT ≥1/150—no direct IPD | 462 407 | 10 635 | 13 312 | 9678 | 2690 | 0 | 615 | 400 | 16 403 | 765 | 556 | 3 | ||